X @Bloomberg
Bloombergยท2025-11-17 12:48
Novo Nordisk is undercutting Eli Lilly on obesity drugs for cash-pay patients as it tries to claw back a larger share of the US market https://t.co/Q72oSTuLO8 ...
Novo Nordisk is undercutting Eli Lilly on obesity drugs for cash-pay patients as it tries to claw back a larger share of the US market https://t.co/Q72oSTuLO8 ...